Ennature Bio Pharma Ltd

NSE: ENNATURE

₹208.85

+₹4.30 (+2.10%)

NSE · 13 Nov 2026, close

Market Cap

₹467 Cr

CMP

₹208.85

52-wk High / Low

₹265 / 190

P/E

61.4

Div Yield

0.00%

Face Value

₹5

Not enough history yet

We have 1 fiscal year and 3 quarters of filings. Most of these scores need at least two full fiscal years to mean anything.

Graham NumberNext 5 quarters of filings

Margin changeNext 5 quarters of filings

Holder deltasAvailable

Piotroski F-ScoreFY2027 results · May 2027

ROE stability, sustainable growthFY2031 · 5 years

	Name	P/E	Mar Cap ₹ Cr	ROCE %	ROE %

	Sep 2025	Jun 2026	Sep 2026
Sales	54	90	78
Expenses	48	80	68
Operating Profit	6	10	10
OPM %	11.2%	11.1%	13.2%
Other Income	0	0	0
Interest	4	0	0
Depreciation	4	4	4
Profit before tax	−1	6	7
Net Profit	−1	5	5
EPS (₹)	−640.00	2,330.00	2.19

	Mar 2026
Sales	246
Expenses	217
Operating Profit	29
OPM %	11.8%
Other Income	0
Interest	13
Depreciation	14
Profit before tax	2
Net Profit	1
EPS (₹)	605.00

	Mar 2026
Cash from Operating Activity	—
Cash from Investing Activity	—
Cash from Financing Activity	—
Net Cash Flow	—

	Mar 2026
ROCE %	—
ROE %	—
EPS (₹)	—
Book Value (₹)	—
Face Value (₹)	5
P/E	61.4
Div Yield %	0.00
NPM %	0.4
OPM %	12.0
D/E	—
P/B	—

	Nov 2026
Promoters	59.63%
FIIs	2.44%
DIIs	4.61%
Government	—
Public	33.33%
No. of shareholders	48,292

Announcements

Board Meeting Outcome for Outcome Of Board Meeting Announcement under Regulation 30 (LODR)-Change in Management Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association Outcome Of Board Meeting Board Meeting Intimation for Board Meeting For Financial Results

Fundamentals from a third-party compiler of exchange filings; prices from the exchanges.© 2026 āagman